GlassScriptPhysician profile
Jennifer E De Niro
NPI 1669782124
$5,493.46
in general payments reported to CMS, 2019-2025
26 companies · $827 in 2025
The $827 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $390 · 2021: $537 · 2022: $1,156 · 2023: $911 · 2024: $1,055 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,774.89 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,093.94 | 2020-2025 | Hydrus Microstent, Rocklatan, Centurion |
| Allergan, INC. | $507.78 | 2019-2022 | |
| Abbvie INC. | $473.87 | 2022-2025 | Lumigan, Durysta |
| Sun Pharmaceutical Industries INC. | $459.21 | 2019-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $408.94 | 2020-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $393.35 | 2019-2023 | |
| Oyster Point Pharma, INC. | $371.75 | 2022-2024 | Tyrvaya, Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $326.54 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $237.59 | 2019-2021 | |
| Glaukos Corporation | $177.28 | 2022-2024 | Radius |
| Harrow Eye, LLC | $175.17 | 2024-2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $171.90 | 2019-2021 | |
| Sight Sciences, INC. | $149.20 | 2022-2024 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $102.73 | 2022-2025 | Tecnis Iol, Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $92.80 | 2025 | Xdemvy |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $85.82 | 2023-2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $68.29 | 2019-2022 | |
| Notal Vision, INC. | $27.39 | 2019 | |
| Ani Pharmaceuticals, INC. | $26.06 | 2024 | Purified Cortrophin Gel |
| Krystal Biotech INC | $24.03 | 2024 | Vyjuvek |
| Shire North American Group INC | $23.39 | 2019 | |
| New World Medical,INC. | $22.80 | 2023 | |
| Akorn, INC. | $20.75 | 2020 | |
| Eyepoint US, INC. | $19.90 | 2021 | |
| Dompe US, INC. | $18.34 | 2022 | |
| Alcon Research LLC | $14.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer De Niro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.